Almirall, S.a.
Clinical trials sponsored by Almirall, S.a., explained in plain language.
-
New injection tested for severe hair loss condition
Disease control Recruiting nowThis study is testing an investigational medicine called LAD603 for adults with severe to very severe alopecia areata, an autoimmune condition causing significant hair loss. Participants will receive either LAD603 or a placebo injection to see if the drug helps hair regrow on the…
Phase: PHASE2 • Sponsor: Almirall, S.A. • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
First human tests begin for new drug candidate
Knowledge-focused Recruiting nowThis is the first study in humans to test a new drug called LAD106. It aims to find out if the drug is safe, how the body processes it, and what side effects it might cause. The study will involve about 93 healthy adult volunteers who will receive either the drug or a placebo. Th…
Phase: PHASE1 • Sponsor: Almirall, S.A. • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:41 UTC